Related Experiment Video
Updated: Apr 16, 2026
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
Identification of vitamin B1 metabolism as a tumor-specific radiosensitizing pathway using a high-throughput colony
Gaganpreet S Tiwana1, Remko Prevo1, Francesca M Buffa1
1Cancer Research UK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, Department of Oncology, University of Oxford, Oxford, UK.
Abstract:
Colony formation is the gold standard assay for determining reproductive cell death after radiation treatment, since effects on proliferation often do not reflect survival. We have developed a high-throughput radiosensitivity screening method based on clonogenicity and screened a siRNA library against kinases. Thiamine pyrophosphokinase-1 (TPK1), a key component of Vitamin B1/thiamine metabolism, was identified as a target for radiosensitization. TPK1 knockdown caused significant radiosensitization in cancer but not normal tissue cell lines. Other means of blocking this pathway, knockdown of thiamine transporter-1 (THTR1) or treatment with the thiamine analogue pyrithiamine hydrobromide (PyrH) caused significant tumor specific radiosensitization. There was persistent DNA damage in cells irradiated after TPK1 and THTR1 knockdown or PyrH treatment. Thus this screen allowed the identification of thiamine metabolism as a novel radiosensitization target that affects DNA repair. Short-term modulation of thiamine metabolism could be a clinically exploitable strategy to achieve tumor specific radiosensitization.
Insights
Researchers identified thiamine metabolism as a novel target for radiosensitization. Modulating thiamine metabolism, specifically targeting thiamine pyrophosphokinase-1 (TPK1), enhances tumor cell death after radiation therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Radiation Oncology
Background:
- Colony formation assays are crucial for assessing reproductive cell death post-radiation.
- Cancer cell proliferation does not always correlate with survival after radiation treatment.
Purpose of the Study:
- To develop a high-throughput screening method for radiosensitivity using clonogenicity.
- To identify novel targets for radiosensitization by screening a siRNA library against kinases.
- To investigate the role of thiamine metabolism in radiation response.
Main Methods:
- Developed a high-throughput radiosensitivity screening assay based on clonogenicity.
- Screened a siRNA library targeting kinases to identify radiosensitization targets.
- Utilized gene knockdown (siRNA) and pharmacological agents (PyrH) to modulate thiamine metabolism.
- Assessed DNA damage persistence in treated cells.
Main Results:
- Thiamine pyrophosphokinase-1 (TPK1) was identified as a key target for radiosensitization.
- TPK1 knockdown led to significant radiosensitization in cancer cells, but not normal cells.
- Inhibition of thiamine transport (THTR1 knockdown) or thiamine analogue treatment (PyrH) also resulted in tumor-specific radiosensitization.
- Persistent DNA damage was observed in cells following TPK1/THTR1 knockdown or PyrH treatment.
Conclusions:
- Thiamine metabolism represents a novel target for achieving tumor-specific radiosensitization.
- Modulation of thiamine metabolism impacts DNA repair mechanisms, enhancing radiosensitivity.
- Short-term interventions targeting thiamine metabolism may offer a clinically viable strategy for improving radiation therapy outcomes.
More Related Videos
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
12:22A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019